跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 260 条关于
“MYH9-RD”
全部
260
临床试验
113
药物
79
机构
5
资讯
63
去年
Novel MYH9 Gene Variant Identified in Chinese Child with Rare Hereditary Thrombocytopenia
12个月前
EMA Recommends Amgen's Uplizna for Rare Autoimmune Disease IgG4-RD
去年
Zenas BioPharma Completes Enrollment in Phase 3 IgG4-RD Trial of Obexelimab
去年
Inebilizumab Shows Promise in Myasthenia Gravis, Phase 3 Data Suggests
2个月前
Innovent and Spero Strike $1.1 Billion Deal for Third-Generation Anti-CD40L Antibody Targeting IgG4-RD and Sjögren's Disease
去年
IgG4-Related Disease: Clinical Trials Update and Emerging Therapies
3年前
Inebilizumab Shows Promise in Preventing Flares in IgG4-Related Disease: MITIGATE Trial Results
4年前
Comparative Efficacy of Treatment Regimens for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
去年
UPLIZNA Becomes First FDA-Approved Treatment for IgG4-Related Disease, Reducing Flare Risk by 87%
去年
Inebilizumab Shows Promise in Reducing Flares in IgG4-Related Disease
第 1 页,共 7 页
上一页
下一页